The Seed Money Arrived. The Bridge Didn't.

Faraz Rizvi × Foundry · 5 July 2026 · 7 min read · Markdown

Faraz Rizvi is a UK operator-practitioner writing about the work between a research breakthrough and a fundable company. He runs SpinUp Forge. Foundry is SpinUp Forge’s custom agentic harness.

UK university spinout formation has dropped from 202 new companies in 2020/21 to 141 in 2024/25, a continuous four-year decline confirmed by HESA data published in Times Higher Education (30 April 2026). Bravo if you are a spinout founder who made it through formation and raised seed capital, but that trend is not your immediate problem. Your problem is what comes after the seed cheque clears — and the data on that is less encouraging than the system’s recent story of reform suggests.

The gap nobody announced

The seed money is easier to find. The bridge is where spinouts are stalling.

The question founders ask me most consistently in the seed-to-Series-A window is some version of: why is it harder to raise a Series A than it was to raise seed?

The answer is visible in the first official national dataset of UK university spinouts. The University Commercialisation and Innovation Policy Evidence Unit at Cambridge (UCI) published its flagship analytical report on the UK Spinout Register in June 2025, the first time this full-population data has been systematically analysed (UCI/IfM, June 2025). One finding is the one to fix on. Early-stage venture capital — the Series A money that carries a spinout from proof point to scaling company — peaked at £1.1 billion in 2021 and fell to £456 million by 2024, below pre-pandemic levels, even as pre-seed and seed funding climbed from around £100 million in 2019 to £193 million (UCI/IfM, Powering Ideas to Innovation, Figure 27, June 2025).

That pattern is not what the headlines imply. The equity reform worked. The Tracey/USIT guidelines moved university equity to a decade low. The narrative that reached most founders since those reforms was that the system was opening up, capital was more accessible, and the path to a funded spinout had become more viable.

It has at pre-seed and seed. The British Business Bank announced on 25 June 2026 a £90m cornerstone commitment across 10 new microfunds (fund sizes typically £10–20m) as the first deployment under its £400m Investor Pathways Capital initiative, explicitly targeting first-time and under-represented fund managers investing at pre-seed and seed (BBB, June 2026). That thickening of the pre-seed layer is real and welcome.

The problem is what comes next. Unfortunately, the improvement you have heard about stops at the gate you already passed.

Why the bridge is different

A seed cheque funds a proof point. A Series A cheque funds a company.

The second question founders ask is sharper: what makes Series A different from seed, and why does the gap feel structural rather than cyclical?

Formation itself is declining. The HESA data reported by Times Higher Education shows 202 spinouts founded in 2020/21 (the pandemic-era peak) falling to 141 in 2024/25, with the number declining continuously each year between those two points. UCI’s analytical report describes this as one of several “worrying headwinds.” Fewer spinouts entering the pipeline, combined with early-stage VC below pre-pandemic levels, means the bridge between seed and Series A is both harder to cross and carrying fewer companies toward it.

But the deeper issue is not supply. It is what Series A investors are actually buying.

A seed cheque buys a proof point — a result, a prototype, a dataset, a founding team with credible domain knowledge. The investor is funding evidence that the science is real and the founders are capable. Most spinouts that reach seed stage have a compelling version of that story. The TTO process validated the IP. The university’s name is on the company. The founding team has publications.

A Series A cheque — in the current market, typically the first institutional round, led by a VC fund writing a single-digit-millions cheque — buys a company. The investor needs to believe that the organisation producing the science can also produce customers, revenue, and returns. That requires operating evidence: a commercial pipeline with named conversations and realistic timelines, a financial model grounded in actual cost-drivers rather than TAM projections, a governance structure that gives a board something to review.

The challenge to founders is an operating-evidence gap. The system producing spinouts has improved its ability to create investable proof points at the scientific stage. It has not yet consistently produced the operating evidence layer that bridges proof-of-concept to a fundable company. That is what the early-stage VC data is measuring when it falls below pre-pandemic even as seed grows: Series A investors are not seeing enough of what they need to write the next cheque.

What closing the gap requires

The founders who cross the bridge are not the ones with the best science. They are the ones who ran a company before they needed to.

The third question is practical: what should I be doing now, in the seed-to-Series-A window?

The answer is to treat the window as a company-building period, not a fundraising preparation period. Those look similar from the outside and are entirely different in substance.

A spinout in fundraising mode produces a pitch deck and a financial model built backwards from the ask. Company building produces commercial conversations, operating decisions, and a record of how the founding team responds to friction. A Series A investor does not read a pitch deck backwards from the raise date. They read the operating history backwards from the raise date. The pitch deck summarises what they have already formed a view on by the time you are in a room together.

What that means practically: a named commercial pipeline — not “we are in conversations with five NHS trusts” but a named list with stage, timeline, and the specific blocker at each is worth more at Series A than a revised TAM analysis. A financial model with real cost-drivers (lab costs, headcount, regulatory timeline) built and updated monthly is worth more than a model built once to accompany the deck. A board-pack cadence established six months before Series A even with a lightweight advisory board — demonstrates that the governance reflex already exists.

The founding team who makes it across the bridge is the one who started building the operating cadence layer the month after seed closed. What you produce in the next six months is the evidence a Series A investor will read when you are eventually in their office. Start producing it now — the month after seed closes, under actual operating conditions, and not when you are booking the Series A meetings.

← Back to SpinUp Forge